BasslerN., JäkelO., SøndergaardC.S., and PetersenJ.B. (2010). ‘Dose-and LET-painting with particle therapy,’ Acta Oncol. (Madr)49, 1170–1176.
2.
BasslerN., ToftegaardJ., LuhrA., SorensenB.S., ScifoniE., KramerM., JäkelO., MortensenL.S., OvergaardJ., and PetersenJ.B. (2014). ‘LET-painting increases tumour control probability in hypoxic tumours,’ Acta Oncol.53, 25–32.
3.
BöhlenT.T., BronsS., DosanjhM., FerrariA., FossatiP., HabererT., PateraV., and MairaniA. (2012). ‘Investigating the robustness of ion beam therapy treatment plans to uncertainties in biological treatment parameters,’ Phys. Med. Biol.57, 7983–8004.
4.
CabalG.A., and JäkelO. (2013). ‘Dynamic target definition: a novel approach for PTV definition in ion beam therapy,’ Radiother. Oncol.107, 227–233.
5.
CaoW., LimG.J., LeeA., LiY., LiuW., Ronald ZhuX., and ZhangX. (2012). ‘Uncertainty incorporated beam angle optimization for IMPT treatment planning,’ Med. Phys.39, 5248–5256.
6.
ChenG.T., SinghR.P., CastroJ.R., LymanJ.T., and QuiveyJ.M. (1979). ‘Treatment planning for heavy ion radiotherapy,’ Int. J. Radiat. Oncol. Biol. Phys.5, 1809–1819.
7.
DeutschmannH., NeunerM., SteiningerP., PinzgerM., BuckM., and SedlmayerF. (2013). ‘Robotic positioning and imaging,’ Strahlenther. Onkol.185.
8.
DiasM.F., RiboldiM., SecoJ., CastelhanoI., PellaA., MirandolaA., PeraltaL., CioccaM., OrecchiaR., and BaroniG. (2015). ‘Scan path optimization with/without clustering for active beam delivery in charged particle therapy,’ Phys. Med.31, 130–136.
9.
DreherC., ScholzC., PommerM., BronsS., ProkeschH., EckerS., DebusJ., JäkelO., CombsS.E., and HabermehlD. (2016). ‘Optimization of carbon ion treatment plans by integrating tissue specific alpha/beta-values for patients with non-resectable pancreatic cancer,’ PLoS One11, e0164473.
10.
EdmundJ.M., and NyholmT. (2017). ‘A review of substitute CT generation for MRI-only radiation therapy,’ Radiat. Oncol.12.
11.
EllerbrockM., JäkelO., KrämerM., NikoghosyanA., and Schulz-ErtnerD. (2006). ‘Clinical implementation of multiple field dose optimization in heavy ion treatment planning,’ Radiother. Oncol.81, 358.
12.
EllerbrockM., JäkelO., KrämerM., NikoghosyanA., and Schulz-ErtnerD. (2007). ‘Clinical implementation of intensity modulated heavy ion therapy,’ Radiother. Oncol.129.
13.
EndoM., Koyama-itoH., MinoharaS., MiyaharaN., TomuraH., KanaiT., KawachiK., TsujiiH., and MoritaK. (1996). ‘HIPLAN – a heavy ion treatment planning system at HIMAC,’ J. Jpn. Soc. Ther. Radiol. Oncol.8, 231–238.
14.
GemmelA., HaschB., EllerbrockM., WeyratherW.K., and KramerM. (2008). ‘Biological dose optimization with multiple ion fields,’ Phys. Med. Biol.53, 6991–7012.
15.
GottschalkB. (2010). ‘On the scattering power of radiotherapy protons,’ Med. Phys.37, 352–367.
16.
HabererT., BecherW., SchardtD., and KraftG. (1993). ‘Magnetic scanning system for heavy-ion therapy,’ Nucl. Instrum. Methods Phys. Res. A330, 296–305.
17.
HaraY., FurukawaT., InaniwaT., MizushimaK., ShiraiT., and NodaK. (2014). ‘A novel method for experimental characterization of large-angle scattered particles in scanned carbon-ion therapy,’ Med. Phys.41, 021706.
18.
HongL., GoiteinM., BuccioliniM., ComiskeyR., GottschalkB., RosenthalS., SeragoC., and UrieM. (1996). ‘A pencil beam algorithm for proton dose calculations,’ Phys. Med. Biol.41, 1305–1330.
19.
HünemohrN., PaganettiH., GreilichS., JäkelO., and SecoJ. (2014). ‘Tissue decomposition from dual energy CT data for MC based dose calculation in particle therapy,’ Med. Phys.41, 061714.
20.
ICRU (2005). International Commission on Radiation Units and Measurements. Stopping of Ions Heavier than Helium. ICRU Report 73, J. ICRU Vol. 5(1) (Oxford University Press, Oxford).
21.
ICRU (2007). International Commission on Radiation Units and Measurements. Prescribing, Recording, and Reporting Proton-Beam Therapy. ICRU Report 78, J. ICRU Vol. 7(2) (Oxford University Press, Oxford).
22.
ICRU (2014). International Commission on Radiation Units and Measurements. Key Data for Ionizing-Radiation Dosimetry: Measurement Standards and Applications. ICRU Report 90, J. ICRU Vol. 14(1) (Oxford University Press, Oxford).
23.
InaniwaT., and KanematsuN. (2014). ‘A trichrome beam model for biological dose calculation in scanned carbon-ion radiotherapy treatment planning,’ Phys. Med. Biol.60, 437.
24.
InaniwaT., FurukawaT., MatsufujiN., KohnoT., SatoS., NodaK., and KanaiT. (2007a). ‘Clinical ion beams: semi-analytical calculation of their quality,’ Phys. Med. Biol.52, 7261.
25.
InaniwaT., FurukawaT., TomitaniT., SatoS., NodaK., and KanaiT. (2007b). ‘Optimization for fast‐scanning irradiation in particle therapy,’ Med. Phys.34, 3302–3311.
26.
InaniwaT., FurukawaT., SatoS., MoriS., TomitaniT., KanematsuN., MinoharaS., NodaK., and KanaiT. (2008). ‘Treatment planning for carbon beam,’ pp. 101–114 in NIRS-MD Anderson Symposium on Clinical Issues for Particle Therapy, (Houston, TX, USA).
27.
InaniwaT., KanematsuN., HaraY., FurukawaT., FukahoriM., NakaoM., and ShiraiT. (2014a). ‘Implementation of a triple Gaussian beam model with subdivision and redefinition against density heterogeneities in treatment planning for scanned carbon-ion radiotherapy,’ Phys. Med. Biol.59, 5361–5386.
28.
InaniwaT., KanematsuN., HaraY., and FurukawaT. (2014b). ‘Nuclear-interaction correction of integrated depth dose in carbon-ion radiotherapy treatment planning,’ Phys. Med. Biol.60, 421.
29.
InaniwaT., KanematsuN., TsujiH., and KamadaT. (2015a). ‘Influence of nuclear interactions in body tissues on tumor dose in carbon-ion radiotherapy,’ Med. Phys.42, 7132–7137.
30.
InaniwaT., KanematsuN., MatsufujiN., KanaiT., ShiraiT., NodaK., TsujiH., KamadaT., and TsujiiH. (2015b). ‘Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan,’ Phys. Med. Biol.60, 3271–3286.
31.
JäkelO. (2006). ‘Ranges of ions in metals for use in particle treatment planning,’ Phys. Med. Biol.51, N173–N177.
32.
JäkelO., and ReissP. (2007). ‘The influence of metal artefacts on the range of ion beams,’ Phys. Med. Biol.52, 635–644.
33.
JäkelO., JacobC., SchardtD., KargerC.P., and HartmannG.H. (2001a). ‘Relation between carbon ion ranges and x-ray CT numbers,’ Med. Phys.28, 701–703.
34.
JäkelO., KramerM., KargerC.P., and DebusJ. (2001b). ‘Treatment planning for heavy ion radiotherapy: clinical implementation and application,’ Phys. Med. Biol.46, 1101–1116.
35.
JohnsonR.P., BashkirovV., DeWittL., GiacomettiV., HurleyR.F., PiersimoniP., PlautzT.E., SadrozinskiH.F.-W., SchubertK., and SchulteR. (2016). ‘A fast experimental scanner for proton CT: Technical performance and first experience with phantom scans,’ IEEE Trans. Nucl. Sci.63, 52–60.
36.
KanaiT., EndoM., MinoharaS., MiyaharaN., Koyama-itoH., TomuraH., MatsufujiN., FutamiY., FukumuraA., HiraokaT., FurusawaY., AndoK., SuzukiM., SogaF., and KawachiK. (1999). ‘Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy,’ Int. J. Radiat. Oncol. Biol. Phys.44, 201–210.
37.
KanematsuN. (2009). ‘Semi-empirical formulation of multiple scattering for the Gaussian beam model of heavy charged particles stopping in tissue-like matter,’ Phys. Med. Biol.54, N67–N73.
38.
KanematsuN., EndoM., FutamiY., KanaiT., AsakuraH., OkaH., and YusaK. (2002). ‘Treatment planning for the layer-stacking irradiation system for three-dimensional conformal heavy-ion radiotherapy,’ Med. Phys.29, 2823–2829.
39.
KanematsuN., MatsufujiN., KohnoR., MinoharaS., and KanaiT. (2003). ‘A CT calibration method based on the polybinary tissue model for radiotherapy treatment planning,’ Phys. Med. Biol.48, 1053–1064.
40.
KanematsuN., TorikoshiM., MizotaM., and KanaiT. (2007). ‘Secondary range shifting with range compensator for reduction of beam data library in heavy-ion radiotherapy,’ Med. Phys.34, 1907–1910.
41.
KanematsuN., InaniwaT., and NakaoM. (2016). ‘Modeling of body tissues for Monte Carlo simulation of radiotherapy treatments planned with conventional x-ray CT systems,’ Phys. Med. Biol.61, 5037–5050.
42.
KargerC.P., JäkelO., DebusJ., KuhnS., and HartmannG.H. (2001). ‘Three-dimensional accuracy and interfractional reproducibility of patient fixation and positioning using a stereotactic head mask system,’ Int. J. Radiat. Oncol Biol. Phys.49, 1493–1504.
43.
KaseY., KanematsuN., KanaiT., and MatsufujiN. (2006). ‘Biological dose calculation with Monte Carlo physics simulation for heavy-ion radiotherapy,’ Phys. Med. Biol.51, N467–N475.
44.
KrämerM. (2001). ‘Treatment planning for heavy-ion radiotherapy: biological optimization of multiple beam ports,’ J. Radiat. Res.42, 39–46.
45.
KrämerM., and ScholzM. (2000). ‘Treatment planning for heavy-ion radiotherapy: calculation and optimization of biologically effective dose,’ Phys. Med. Biol.45, 3319–3330.
46.
KrämerM., and JäkelO. (2005). ‘Biological dose optimization using ramp-like dose gradients in ion irradiation fields,’ Phys. Med.21, 107–111.
47.
KrämerM., and ScholzM. (2006). ‘Rapid calculation of biological effects in ion radiotherapy,’ Phys. Med. Biol.51, 1959–1970.
48.
KrämerM., JäkelO., HabererT., KraftG., SchardtD., and WeberU. (2000). ‘Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization,’ Phys. Med. Biol.45, 3299–3317.
49.
LiQ.A., DaiZ.Y., YanZ., JinX.D., LiuX.G., and XiaoG.Q. (2007). ‘Heavy-ion conformal irradiation in the shallow-seated tumor therapy terminal at HIRFL,’ Med. Biol. Eng. Comput.45, 1037–1043.
50.
LomaxA.J. (2008a). ‘Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: the potential effects of calculational uncertainties,’ Phys. Med. Biol.53, 1027–1042.
51.
LomaxA.J. (2008b). ‘Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions,’ Phys. Med. Biol.53, 1043–1056.
52.
MairaniA., BronsS., CeruttiF., FassoA., FerrariA., KramerM., ParodiK., ScholzM., and SommererF. (2010). ‘The FLUKA Monte Carlo code coupled with the local effect model for biological calculations in carbon ion therapy,’ Phys. Med. Biol.55, 4273–4289.
53.
MatsufujiN., FukumuraA., KomoriM., KanaiT., and KohnoT. (2003). ‘Influence of fragment reaction of relativistic heavy charged particles on heavy-ion radiotherapy,’ Phys. Med. Biol.48, 1605–1623.
54.
MatsufujiN., KomoriM., SasakiH., AkiuK., OgawaM., FukumuraA., UrakabeE., InaniwaT., NishioT., KohnoT., and KanaiT. (2005). ‘Spatial fragment distribution from a therapeutic pencil-like carbon beam in water,’ Phys. Med. Biol.50, 3393–3403.
55.
MinoharaS., KanaiT., EndoM., NodaK., and KanazawaM. (2000). ‘Respiratory gated irradiation system for heavy-ion radiotherapy,’ Int. J. Radiat. Oncol. Biol. Phys.47, 1097–1103.
56.
MöhlerC., WohlfahrtP., RichterC., and GreilichS. (2016). ‘Range prediction for tissue mixtures based on dual-energy CT,’ Phys. Med. Biol.61, N268–N275.
57.
MoriS., ZenklusenS., and KnopfA.C. (2013). ‘Current status and future prospects of multi-dimensional image-guided particle therapy,’ Radiol. Phys. Technol.6, 249–272.
58.
MoriS., InaniwaT., MikiK., ShiraiT., and NodaK. (2014a). ‘Implementation of a target volume design function for intrafractional range variation in a particle beam treatment planning system,’ Br. J. Radiol.87, 20140233.
59.
NairzO., WinterM., HeegP., and JäkelO. (2013). ‘Accuracy of robotic patient positioners used in ion beam therapy,’ Radiat. Oncol.8, 124.
60.
NewhauserW.D., RechnerL., MirkovicD., YepesP., KochN.C., TittU., FontenotJ.D., and ZhangR. (2013). ‘Benchmark measurements and simulations of dose perturbations due to metallic spheres in proton beams,’ Radiat. Meas.58, 37–44.
61.
PaganettiH. (2002). ‘Nuclear interactions in proton therapy: dose and relative biological effect distributions originating from primary and secondary particles,’ Phys. Med. Biol.47, 747–764.
62.
PardoJ., DonettiM., BourhalebF., AnsarinejadA., AttiliA., CirioR., GarellaM.A., GiordanengoS., GivehchiN., La RosaA., MarchettoF., MonacoV., PeckaA., PeroniC., RussoG., and SacchiR. (2009). ‘Heuristic optimization of the scanning path of particle therapy beams,’ Med. Phys.36, 2043–2051.
63.
ParodiK., MairaniA., BronsS., NaumannJ., SommererF., and HabererT. (2009). ‘The application of the FLUKA Monte Carlo code to basic data generation for clinical treatment planning of scanned proton and carbon ion therapy,’ in Second European Workshop on Monte Carlo Treatment Planning, (Cardiff, UK).
64.
ParodiK., MairaniA., BronsS., HaschB.G., SommererF., NaumannJ., JäkelO., HabererT., and DebusJ. (2012). ‘Monte Carlo simulations to support start-up and treatment planning of scanned proton and carbon ion therapy at a synchrotron-based facility,’ Phys. Med. Biol.57, 3759–3784.
65.
PellaA., RiboldiM., TagasteB., BianculliD., DesplanquesM., FontanaG., CerveriP., SeregniM., FattoriG., OrecchiaR., and BaroniG. (2014). ‘Commissioning and quality assurance of an integrated system for patient positioning and setup verification in particle therapy,’ Technol. Cancer Res. Treat.13, 303–314.
PflugfelderD., WilkensJ.J., and OelfkeU. (2008). ‘Worst case optimization: a method to account for uncertainties in the optimization of intensity modulated proton therapy,’ Phys. Med. Biol.53, 1689–1700.
68.
RietzelE., SchardtD., and HabererT. (2007). ‘Range accuracy in carbon ion treatment planning based on CT-calibration with real tissue samples,’ Radiat. Oncol.2, 14.
69.
SchneiderU., PedroniE., and LomaxA. (1996). ‘The calibration of CT Hounsfield units for radiotherapy treatment planning,’ Phys. Med. Biol.41, 111–124.
70.
SchuemannJ., DowdellS., GrassbergerC., MinC.H., and PaganettiH. (2014). ‘Site-specific range uncertainties caused by dose calculation algorithms for proton therapy,’ Phys. Med. Biol.59, 4007–4031.
71.
Schulz-ErtnerD., NikoghosyanA., DidingerB., MünterM., JäkelO., KargerC.P., and DebusJ. (2005). ‘Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques,’ Cancer104, 338–344.
72.
SchwahoferA., BarE., KuchenbeckerS., GrossmannJ.G., KachelriessM., and SterzingF. (2015). ‘The application of metal artifact reduction (MAR) in CT scans for radiation oncology by monoenergetic extrapolation with a DECT scanner,’ Z. Med. Phys.25, 314–325.
73.
SihverL., TsaoC.H., SilberbergR., BarghoutyA.F., and KanaiT. (1996). ‘Calculations of depth-dose distributions, cross sections and momentum loss,’ Adv. Space Res.17, 105–108.
74.
SteitzJ., NaumannP., UlrichS., HaefnerM.F., SterzingF., OelfkeU., and BangertM. (2016). ‘Worst case optimization for interfractional motion mitigation in carbon ion therapy of pancreatic cancer,’ Radiat. Oncol.11, 134.
75.
TashiroM., IshiiT., KoyaJ., OkadaR., KurosawaY., AraiK., AbeS., OhashiY., ShimadaH., YusaK., KanaiT., YamadaS., KawamuraH., EbaraT., OhnoT., and NakanoT. (2013). ‘Technical approach to individualized respiratory-gated carbon-ion therapy for mobile organs,’ Radiol. Phys. Technol.6, 356–366.
76.
TelsemeyerJ., AckermannB., EckerS., JäkelO., and MartišíkováM. (2014). ‘Experimental verification of ion range calculation in a treatment planning system using a flat-panel detector,’ Phys. Med. Biol.59, 3737.
77.
UrieM., GoiteinM., and WagnerM. (1984). ‘Compensating for heterogeneities in proton radiation therapy,’ Phys. Med. Biol.29, 553–566.
78.
WeberU., and KraftG. (2009). ‘Comparison of carbon ions versus protons,’ Cancer J.15, 325–332.
79.
WertzH., and JäkelO. (2004). ‘Influence of iodine contrast agent on the range of ion beams for radiotherapy,’ Med. Phys.31, 767–773.
80.
ZhangH., LiS., WangX.H., LiQ., WeiS.H., GaoL.Y., ZhaoW.P., HuZ.G., MaoR.S., XuH.S., ZhangQ.N., YueY.J., TianZ.Z., RanJ.T., XiaoG.Q., and ZhanW.L. (2012). ‘Results of carbon ion radiotherapy for skin carcinomas in 45 patients,’ Br. J. Dermatol.166, 1100–1106.